Search results
Results From The WOW.Com Content Network
Similar to the NINCDS-ADRDA Alzheimer's Criteria are the DSM-IV-TR criteria published by the American Psychiatric Association. [3] At the same time the advances in functional neuroimaging techniques such as PET or SPECT that have already proven their utility to differentiate Alzheimer's disease from other possible causes, [4] have led to proposals of revision of the NINCDS-ADRDA criteria that ...
Medication Appropriateness Tool for Comorbid Health conditions during Dementia. The Medication Appropriateness Tool for Comorbid Health conditions during Dementia ( MATCH-D) criteria supports clinicians to manage medication use specifically for people with dementia without focusing only on the management of the dementia itself. [1] [2]
Posterior cortical atrophy ( PCA ), also called Benson's syndrome, is a rare form of dementia which is considered a visual variant or an atypical variant of Alzheimer's disease (AD). [ 1][ 2][ 3] The disease causes atrophy of the posterior part of the cerebral cortex, resulting in the progressive disruption of complex visual processing. [ 4]
The benefit of Eisai and Biogen's Alzheimer's drug Leqembi in patients with early-stage Alzheimer's appears to increase with continued use with no new safety issues, according to three-year data ...
Purpose. test cognitive impairment. The Addenbrooke's Cognitive Examination (ACE) and its subsequent versions (Addenbrooke's Cognitive Examination-Revised, ACE-R [ 1] and Addenbrooke's Cognitive Examination III, ACE-III) are neuropsychological tests used to identify cognitive impairment in conditions such as dementia .
Scientists announced in December the successful creation of the Brain Care Score, a tool for assessing dementia or stroke risk without medical procedures. That score, which also helps patients and ...
Leqembi’s side effects and other potential issues. Leqembi offers doctors the first new Alzheimer’s treatment option in years. But it also has some possibly dangerous side effects. Those ...
Steroid dementia syndrome. Steroid dementia syndrome describes the signs and symptoms of hippocampal and prefrontal cortical dysfunction, such as deficits in memory, attention, and executive function, induced by glucocorticoids. [ 1] Dementia-like symptoms have been found in some individuals who have been exposed to glucocorticoid medication ...